Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyWu Xiaohui of Wanhuida Intellectual Property explains a pioneering case heard by the Intellectual Property Court of the Supreme People’s Court and considers its implications for original and generic drug makers -
Sponsored by NokiaManaging IP sat down with Nokia’s head of multimedia technologies, Ville-Veikko Mattila, to discuss the cutting-edge applications of Versatile Video Coding, and the societal challenges that could be overcome via digital standardisation
-
Sponsored by Gün and PartnersZeynep Seda Alhas, Pınar Arıkan and Baran Güney of Gün + Partners identify several shortcomings with the new provisions regarding domain name disputes in Turkey
-
Sponsored by Kangxin PartnersRuixian Liu of Kangxin Partners considers what patentees can do to prevent claims being declared invalid because their amendments go beyond the scope of the original application
-
Sponsored by Wanhuida Intellectual PropertyJianhui Li of Wanhuida Intellectual Property explains how China addresses the question of whether the features of an administration process limit a patented product and distinguish it from prior art
-
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property reports on a case in China that has implications for the drafting of compound patents incorporating Markush claims
